Suppr超能文献

变应性鼻炎和屋尘螨致敏决定儿童哮喘的持续性。

Allergic Rhinitis and House Dust Mite Sensitization Determine Persistence of Asthma in Children.

机构信息

Department of Pediatrics and Allergy, N. Copernicus Hospital, Medical University of Lodz, 71 Al. Pilsudskiego, 90-329, Lodz, Poland.

Department of Internal Medicine, Asthma and Allergy, N. Copernicus Hospital, Medical University of Lodz, Lodz, Poland.

出版信息

Indian J Pediatr. 2022 Jul;89(7):673-681. doi: 10.1007/s12098-021-04052-5. Epub 2022 Mar 4.

Abstract

OBJECTIVE

To specify clinical and immunological parameters of the mechanisms, which may lead to development of persistent asthma, or regression of the disease symptoms.

METHODS

Eighty children with childhood asthma, diagnosed in the past by using the modified Asthma Predicted Index (mAPI), were divided into two groups: remission group and persistent group. There were 3 study visits (baseline, at 6 mo, and at 12 mo). Clinical remission of asthma was defined as the absence of asthma symptoms for at least 12 mo without treatment. The patients could switch from one group to another during the 12 mo of follow-up. Clinical, inflammatory, and immunoregulatory predictors of asthma remission/persistence were analyzed.

RESULTS

The presence of mAPI criteria as well as house dust mite (HDM) allergy and allergic rhinitis at 7-10 y, were associated with a reduced prevalence of asthma remission. The increased eosinophil blood count in mAPI criteria was associated with a lower expression of CD25 positive cells. HDM allergy was associated with a higher fractional exhaled nitric oxide (FeNO) level (p = 0.0061) and higher expression of CD25CD71 (p = 0.0232). Allergic rhinitis was associated with a higher expression of PPAR (p = 0.0493) and CD25CD71 (p = 0.0198), and lower expression of glycoprotein A repetitions predominant (GARP).

CONCLUSIONS

Persistence of childhood asthma was largely determined by the presence of allergic rhinitis and sensitization to HDM. Additionally, API criteria but not immunoregulation processes, were related to asthma persistence.

摘要

目的

明确可能导致持续性哮喘发展或疾病症状消退的临床和免疫学机制参数。

方法

将 80 名过去通过改良哮喘预测指数(mAPI)诊断为儿童哮喘的儿童分为缓解组和持续组。共进行 3 次研究访视(基线、6 个月和 12 个月)。哮喘临床缓解定义为至少 12 个月无治疗且无哮喘症状。在 12 个月的随访期间,患者可从一组转为另一组。分析哮喘缓解/持续的临床、炎症和免疫调节预测因素。

结果

7-10 岁时存在 mAPI 标准以及屋尘螨(HDM)过敏和过敏性鼻炎与哮喘缓解率降低有关。mAPI 标准中嗜酸性粒细胞血计数增加与 CD25 阳性细胞表达降低有关。HDM 过敏与更高的呼出气一氧化氮分数(FeNO)水平(p=0.0061)和更高的 CD25CD71 表达(p=0.0232)有关。过敏性鼻炎与更高的过氧化物酶体增殖物激活受体(PPAR)表达(p=0.0493)和 CD25CD71 表达(p=0.0198)以及糖蛋白 A 重复为主(GARP)表达降低有关。

结论

儿童哮喘的持续性在很大程度上取决于过敏性鼻炎和对 HDM 的致敏。此外,API 标准而不是免疫调节过程与哮喘的持续存在有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ee8/9205813/f42e7706072b/12098_2021_4052_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验